Company Presentation • 22 Jan 2026 22:00
Q4 2025 TU
Company Presentation • 17 Aug 2021 14:00
H1 2021
Company Presentation • 03 Mar 2022 15:00
Investor Update
Company Presentation • 30 Jun 2022 14:00
H2 2021
Company Presentation • 14 Dec 2022 15:00
𝛼SK or SearchENTITY
Shield Therapeutics (STX LN)
Shield Therapeutics (STX LN)
47
Analysis
Health Care • United Kingdom
Shield Therapeutics is a commercial-stage specialty pharmaceutical company focused on pharmaceuticals for unmet medical needs. Its primary product, Accrufer/Feraccru (ferric maltol), is an oral therapy for iron deficiency with or without anemia. The company was founded in 2008 and is headquartered in Gateshead, United Kingdom.
morex